Alonso Krangle LLP is currently offering free Zoloft lawsuit evaluations to any family who believes their child’s birth defect was the result of their mother’s use of Zoloft during pregnancy.
Melville, NY (PRWEB) February 22, 2012
Attorneys Andres Alonso and David Krangle, founding partners of Alonso Krangle LLP, a national law firm focused on fighting for the rights of serious personal injury victims, announce the launch of an investigation into alleged Zoloft birth defects, side effects. Their firm is currently offering free Zoloft lawsuit evaluations to any family who believes their child’s birth defect was the result of their mother’s use of Zoloft during pregnancy. Birth defect side effects allegedly associated with the use of Zoloft and other selective serotonin reuptake inhibitor (SSRI) antidepressants Celexa, Lexapro, Paxil, Prozac, Effexor and Lexapro include:
Atrial and ventrical septal heart defects (ASD/VSD)
Hypoplastic Left Heart Syndrome (HLHS)
Transposition of Great Arteries
Coarctation of the Aorta (CoA)
Tetralogy of Fallot (TOF)
Skull defects, Craniosynostosis
Persistent Pulmonary Hypertension of the Newborn
Neural tube defects of the brain and spinal cord
Limb reduction defects
Oral Clefts, Cleft Lip and Cleft Palate
In addition to Zoloft, the defective drug lawyers at Alonso Krangle LLP are also investigating possible links between other SSRI antidepressants and birth defects. Additional medications currently under investigation include:
To discuss a potential Zoloft or SSRI antidepressant birth defect lawsuit with one of the experienced and compassionate defective drug lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com
What is Zoloft?
Zoloft is an SSRI antidepressant marketed by Pfizer Inc. that was approved by the U.S. Food & Drug Administration (FDA) in 1991. Zoloft is used to treat major depression, obsessive-compulsive disorder, panic disorder and anxiety disorders. SSRI antidepressants like Zoloft relieve patients’ system by altering the balance of the serotonin in the brain.
According to the [mayoclinic.com/health/ssris/MH00066] Mayo Clinic, SSRIs are the most commonly prescribed antidepressants. However, a number of studies have linked SSRI antidepressants, including Zoloft, to an increased risk of birth defects when they are used during pregnancy, especially in the first trimester, when many expectant mothers do not know they are pregnant. In 2006, a study published by the [nejm.org/doi/full/10.1056/NEJMoa052744] New England Journal of Medicine found that women who used SSRIs like Zoloft after the 20th week of pregnancy were six times more likely to give birth to an infant with persistent pulmonary hypertension of the newborn (PPHN). In another study published in the [nejm.org/doi/full/10.1056/NEJMoa067407] New England Journal of Medicine in 2007, researchers found that babies born to women who used Zoloft during the first trimester of pregnancy were twice as likely to suffer heart-related birth defects. The most common heart defects seen in that study were ventricular outflow defects and septal defects.
Just last month, a study conducted by researchers at Sweden’s Karolinska Institutace found that children born to women who took SSRI antidepressants, including Zoloft, face double the risk of having a baby born with PPHN, a life-threatening lung condition. The study, published in the [bmj.com/content/344/bmj.d8012] British Medical Journal, involved 1.6 million live births in five Nordic countries that occurred from 1996 through 2007.
At least 59 lawsuits have been filed in courts throughout the U.S. alleging a mother’s use of Zoloft was responsible for a child’s birth defects. Recently, Pfizer filed a motion with the U.S. Judicial Panel on Multidistrict Litigation seeking the consolidation of all Zoloft birth defect lawsuits in a multidistrict litigation (MDL No. 2342). Pfizer requested that the proposed Zoloft MDL be transferred to the U.S. District Court for the Southern District of New York or, alternatively, the U.S. District Court for the Northern District of Mississippi, the U.S. District Court for the Southern District of Mississippi, or the U.S. District Court for the Northern District of Ohio. According to a [jpml.uscourts.gov/Hearing_Order-3-29-12.pdf] notice issued on February 13, the Panel will hear oral arguments on Pfizer’s motion on March 29 in San Diego, California.
There is still time for families who believe Zoloft or another SSRI antidepressant caused their child’s birth defect to file their own lawsuits against the makers of these medications. To discuss a potential claim with one of the experienced and compassionate Zoloft birth defect lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website http://www.FightForVictims.com
About Alonso Krangle LLP
Andres Alonso and David Krangle, attorneys with almost 40 years of collective legal experience, have focused their law practice on the handling of significant personal injury cases, defective drug and medical device litigation, construction site accidents, nursing home abuse, medical negligence, qui tam/whistleblower actions and consumer fraud cases. A national law firm representing injured victims throughout the U.S., Alonso Krangle LLP is headquartered in Long Island, New York, with offices in New York City, and plans to open additional locations in New Jersey.
For more information about Alonso Krangle or to join the fight and be a part of our team, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.
Contact: Alonso Krangle LLP
445 Broad Hollow Road
Melville, New York